The FDA recently approved a new RSV vaccine for pregnant patients who want to protect their newborns from the virus.
The Center for Disease Control said RSV is the leading cause of hospitalizations for children younger than five. It causes over two million doctor visits and up to 300 deaths each year.
According to Norton Healthcare, by vaccinating pregnant patients, a child will be born with some protection against RSV at a time when they are extremely vulnerable.
Studies have shown the vaccine is 82% effective at protecting infants against severe RSV during their first three months.
Source: WAVE
You must be logged in to post a comment.